Delivery Order SPE2DB20D2104-SPE2DB23FU43S
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $503
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,116 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. The prime contractor, a pharmaceutical distribution division of Amerisourcebergen Corporation, will deliver the requested doses...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 4th through August 7th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...
- The Defense Logistics Agency awarded a $359,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania through August 2021. The award was made utilizing the Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle. No set-aside provisions or subcontractors were identified. This supports the...
- The Defense Logistics Agency Troop Support Medical awarded a $554,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract running from June 26-27, 2023. As a prime contractor supporting DLA's medical supply needs, Amerisourcebergen will deliver this testosterone therapy medication to aid the agency's...
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will perform as the prime contractor, with product sourcing and delivery managed through its Corporate Office...
- The Defense Logistics Agency awarded a $594.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone medication. The single order is for delivery to a location in Conshohocken, Pennsylvania by June 27, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities to fulfill agency needs on schedule from its...
- The Defense Logistics Agency awarded a $6,165.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be in Conshohocken, Pennsylvania over the period of August 1-2, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling this order to supply the injectable testosterone cypionate product in support of DLA programs. No major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,727 to Amerisourcebergen Drug Corporation for the supply of 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order...
- The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 10-11, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $16,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562061581 XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the 0.5mL auto-injectable testosterone cypionate product to a location in Conshohocken, Pennsylvania by September 7, 2023 to support the Department of Defense. No subcontractors or set aside designations were identified. This order is likely placed against...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU43SDelivery Order
The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 19, 2023 to support the DLA's medical supply needs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities. The award is made utilizing the DLA's indefinite-delivery/indefinite-quantity Pharmaceutical Prime Vendor contract vehicle to streamline the procurement of various medical commodities for military treatment facilities worldwide.
Generated 12/17/23, 4:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $503 | 7/18/23 |